COVID-19 cases rise to 5,66,840 as Unlock 2.0 begins

▴ COVID-19 cases rise to 5,66,840 as Unlock 2.0 begins
As a country moves towards Unlockdown 2.0 ground realities are still grim

As Unlock-2 begins from Wednesday, India’s COVID-19 tally climbed to 5,66,840 with nearly 66 per case reported in June alone, and a concerned Prime Minister Narendra Modi said it is a cause of worry that people are not strictly adhering to rules and precautions as they did during the lockdown.

From June 1, when relaxations were introduced under Unlock-1, the country has reported 3,76,305 cases. Maharashtra, Tamil Nadu, Delhi and Gujarat account for nearly two-third of the total cases till now.

Speaking on the coronavirus situation, Prime Minister Modi, in his address to the nation on Tuesday, said India is in a better position compared to many countries of the world, as the timely imposition of lockdown and other decisions have saved lakhs of lives.

He, however, lamented that there is an increasing “negligence” in personal and social behaviour during the easing of restrictions and urged them to be more vigilant.

“We have also seen that since ‘Unlock-1’, there is increasing negligence in personal and social behaviour. Earlier, we were very careful with respect to wearing masks, social distancing and washing of hands for 20 seconds. But today, when we need to be more careful, increasing negligence is a cause of worry,” he said and urged the people to follow all necessary precautions.

He emphasized on strict enforcement of rules, especially in containment zones.

“Those not following the rules will need to be stopped and cautioned,” he said, stressing “be it a village pradhan or the prime minister, no one is above the law in India”.

“As the country enters Unlock-2, we are also entering the season of increasing cases of cough, cold and fever. I, therefore, request all of you to take special care of yourselves,” he said.

The prime minister also reviewed vaccine development efforts as well as India’s preparations for vaccinating its vast population once it is available and asserted that vaccination must be affordable and universal.

With 18,522 people testing positive for coronavirus, it was the seventh day in a row that over 15,000 cases have been reported in the country. The death toll rose to 16,893 after 418 new fatalities.

India is the fourth worst-affected country after the US, Brazil and Russia.

As India moves into ‘Unlock 2.0’, here’s where the top three states stood the night before:

(1.) Maharashtra (1,74,761): The western state, also the ‘runaway leader’, has nearly double the number of cases that the next worst-affected state-Tamil Nadu-has. On Tuesday, the state recorded 4,878 new cases, after four straight spikes of over 5,000, and 245 deaths (95 in the last 48 hours and 150 from the previous period). Therefore, it will end ‘Unlock 1.0’ with a total COVID-19 count of 1,74,761. Of these, 90,911 patients have been discharged, 75,979 are active cases and 7,855 deaths. Its recovery rate stands at 52.02%.

(2.) Tamil Nadu (90,167): The southern state recorded nearly 4,000 new cases for the second straight day on Tuesday, crossing the 90,000-mark in the process. With 3,943 new cases and 60 deaths, it will end ‘Unlock 1.0’ with an overall COVID-19 count of 90,167, overtaking Delhi in the process and once again becoming the second worst-hit state. It currently has 50,074 recoveries, 38,889 active cases and 1,201 deaths. Its recovery rate is 55.53%.

On Monday, Tamil Nadu had witnessed its worst 24-hour spike of 3,949.

(3.) Delhi (87,360): The national capital on Tuesday registered a relatively low spike of 2,199, in the process, allowing Tamil Nadu to surpass it and become the third worst-hit state. It will, thus, end Unlock 1.0 with an overall COVID-19 tally of 87,360. Of these, 58,348 are discharged cases, 26,270 are active cases and 2,742 are casualties, including 62 on Tuesday. It has a recovery rate of 66.80%.

Source; PTI,India.com

Tags : #Unlockdown20 #Covid-19 #Delhi #Tamilnadu #Maharashtra #PMModi #LatestCovidNews

About the Author


Team Medicircle

Related Stories

02 Jan

India’s Pharma Industry Faces New Regulatory Storm: Will Drugmakers Adapt to Schedule M?

The revised Schedule M is both a challenge and an opportunity for India’s pharmaceutical sector.

View
19 Oct

Glenmark Launches Zita DM: A Triple-Drug Combination for Type 2 Diabetes for just Rs 14

Glenmark's commitment to providing affordable and effective solutions highlights its role as a leader in diabetes care. As Zita DM becomes a part of the diabetes management landscape, it holds the potential to positively impact the lives of millions of individuals suffering from this chronic condition.

View
10 Oct

Mental Health Struggles of Indian Housewives, we don't talk about

Unveiling Mental Health Challenges of Indian Housewives and Proposed Solutions: Addressing societal pressures, isolation, and financial dependency. Advocating for awareness, empowerment, equal responsibilities, and community support to enhance their mental well-being and foster a supportive environment.

View
16 Sep

Surviving and Thriving: Essential Health Strategies for Young Adults

Hey, squad! Burned out from the chaos? This read spills the deets on the hustle and struggles and how we Gen Z can vibe from burnout to boss balance. Grab some savvy tricks and slay the game!

View
29 Oct

LUVIN, a startup that manufactures pet food, secures $300,000 in funding

The angel round that raised ₹ 2.4 crore (₹ 24 million) for the pet food company LUVIN included $300K from the family office of Gujarat's Possible Ventures, as well as contributions from M.V. Nair and other individuals. The money, according to LUVIN, would be used to expand over all of India, enhance marketing efforts, and diversify its holdings.

View
04 Jul

CARE Hospitals acquires CHL Hospitals

Established in 2001, Convenient Hospitals (CHL) has a capacity of 250 beds and is adding another 150 beds, CARE Hospitals said in a statement. . While the financial terms were not disclosed, people in the know said the deal has valued CHL at ₹350-400 crore.

View
20 Jan

Healthtech company, Wheel, raises $150 million

Health-tech company Wheel has raised $150 million in its Series C funding round led by Lightspeed Venture Partners and Tiger Global.

View
21 Sep

Success story of Aurobindo Pharma

In the period between 1988-89, the company only manufactured penicillin. They have since then expanded into antibiotics, anti-allergic, antiretrovirals, cardiovascular, central nervous system and gastroenterological categories.

View
18 Sep

The success story behind Glenmark

The story begins in 1977. Saldanha starts a pharmaceutical company named after his two sons - Glenn and Mark. This is the beginning of a global pharmaceutical company - Glenmark Pharmaceuticals.

View
16 Sep

Growth of India’s Pharmaceutical Companies

Imagine the year 1969. In our domestic pharmaceutical market, Indian companies had a share of a mere 5%. Cut to last year where they had captured 85% of the market.

View

-Advertisements-




Trending Now

CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025